PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1.44%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Dividend reduction while CX stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-4.24%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-3.41%
Negative 5Y CAGR while CX stands at 43.51%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
33.22%
3Y revenue/share CAGR 1.25-1.5x CX's 22.16%. Bruce Berkowitz might see better product or regional expansions than the competitor.
26.97%
10Y OCF/share CAGR under 50% of CX's 108.33%. Michael Burry would worry about a persistent underperformance in cash creation.
10.06%
Below 50% of CX's 115.00%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
-25.35%
Negative 3Y OCF/share CAGR while CX stands at 23.69%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
518.86%
Positive 10Y CAGR while CX is negative. John Neff might see a substantial advantage in bottom-line trajectory.
18.05%
Positive 5Y CAGR while CX is negative. John Neff might view this as a strong mid-term relative advantage.
197.03%
Positive short-term CAGR while CX is negative. John Neff would see a clear advantage in near-term profit trajectory.
120.25%
Positive growth while CX is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
50.93%
5Y equity/share CAGR above 1.5x CX's 17.43%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
15.48%
Below 50% of CX's 39.37%. Michael Burry suspects a serious short-term disadvantage in building book value.
-100.00%
Cut dividends over 10 years while CX stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-100.00%
Negative 5Y dividend/share CAGR while CX stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-100.00%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
15.06%
Our AR growth while CX is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
5.72%
Inventory growth well above CX's 3.14%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
5.72%
Asset growth at 75-90% of CX's 7.02%. Bill Ackman suggests reviewing opportunities to match or surpass the competitor's asset expansion if profitable.
5.72%
Positive BV/share change while CX is negative. John Neff sees a clear edge over a competitor losing equity.
7.11%
Debt shrinking faster vs. CX's 18.47%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.